Clinical Trial Update: Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy of combining an anti-CD20 antibody with an anti-CD38 antibody in childhood nephrotic syndrome that is multid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• anti-CD20 antibody + anti-CD38 antibody

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Nephrotic Syndrome | Phase 2 | Status: UNKNOWN